Anti-amyloid Alzheimer’s drugs fail to demonstrate significant clinical benefits
Recent comprehensive analysis has cast significant doubt on the clinical value of drugs targeting amyloid beta proteins in the brains ...
Recent comprehensive analysis has cast significant doubt on the clinical value of drugs targeting amyloid beta proteins in the brains ...
In a groundbreaking revelation poised to reshape the landscape of Alzheimer’s disease research, a recent study by Zhou X. published ...
A recent preliminary study led by researchers at Osaka Metropolitan University, Japan, offers new insights into the complex pathophysiology of ...
The treatment landscape of Alzheimer’s disease (AD) has witnessed a transformative shift with the recent approval of the first-ever disease-modifying ...
In a groundbreaking new study published in Nature Communications, researchers have unveiled compelling evidence linking the asymmetric accumulation of two ...
Research into the biological underpinnings of neurodegenerative diseases continues to evolve, with new insights into how sex differences can influence ...
In the relentless quest to unravel the complex pathophysiology of Alzheimer's disease (AD), a groundbreaking study has emerged revealing intricate ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine